Breastfeeding is beneficial to the newborn as breast milk contains nutrients, immune proteins, and other beneficial factors. Some studies suggest that breastfeeding may have a protective effect against developing IBD. It is thought that breastfeeding may help the newborn develop a healthy gut microbiome and immune system by helping newborns develop tolerance to certain bacteria, and thus prevent exaggerated immune responses to bacteria encountered later in life.

BREASTFEEDING: most IBD medications can be continued

Class of medicationExamplesNotes for breastfeeding
Mealamine (5-aminosalicylates)Asacol©, Pentasa©, Salofalk©, Mesavant©, Medications are excreted into the breast milk in very small amounts. Risk of toxicity to the child is very small.
SulfasalazineSulfasalazine (Salazopyrin©)Medications are excreted into the breast milk in very small amounts. Risk of toxicity to the child is very small.
CorticosteroidsPrednisone (Deltasone©), Budesonide (Entocort©, Coritment©)Steroids transfer into the breast milk in small amounts, with highest levels in the first 4 hours after taking the medication.
ImmunosuppressantAzathioprine (Imuran ©), 6-mercaptopurine (6-MP, Purinethol ©)These can be continued while breastfeeding. To minimize the drug levels in the breast milk, mothers can pump and dump the first 4 hours of breast milk after taking the medication
Methotrexate Methotrexate (Rheumatrex©)Contraindicated while breastfeeding.
BiologicsInfliximab, Adalimumab, GolimumabThese can be continued while breastfeeding. Although they cross into the breast milk, the levels are nil to minimal.
Small Molecules (JAK inhibitors)Tofacitinib (Xeljanz©)Contraindicated while breastfeeding.
Small Molecules (S1P modulators)Ozanimod (Zeposia©)Contraindicated while breastfeeding.